[Antiagregants, anticoagulants and proximal femur fracture].
Alexandra MalliouKevin MoerenhoutDaniel WagnerMarc HumbertPublished in: Revue medicale suisse (2023)
Hip fractures are common in the elderly, particularly due to an increased susceptibility to falls and greater bone frailty, especially in women. The consequences of such events are potentially serious. Early management (< 48 hours) significantly reduces the mortality and postoperative complications. Because of their comorbidities, older people are often on antiplatelet therapy, anticoagulant therapy, or both. However, there are no definitive recommendations for the perioperative management of antiplatelet and anticoagulant treatment in the early surgery of hip fractures. The purpose of this article is to review the management of these patients.
Keyphrases
- antiplatelet therapy
- atrial fibrillation
- venous thromboembolism
- percutaneous coronary intervention
- end stage renal disease
- ejection fraction
- minimally invasive
- bone mineral density
- community dwelling
- chronic kidney disease
- stem cells
- cardiovascular events
- coronary artery bypass
- cardiovascular disease
- type diabetes
- squamous cell carcinoma
- prognostic factors
- skeletal muscle
- patients undergoing
- metabolic syndrome
- cardiac surgery
- risk factors
- body composition
- patient reported outcomes
- middle aged
- locally advanced
- soft tissue